Clinical Trial Update: Denosumab Administration After Spinal Cord Injury [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on denosumab administration after spinal cord injury for osteoporosis, with status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Osteoporosis, Spinal Cord Injury | Phase 4 | Status: UNKNOWN